Ned Pagliarulo's articles Biotechnology Sanofi, expanding in radiopharma, strikes a joint venture deal The French drugmaker will invest 300 million euros into a new entity that will develop lead isotope-based therapies for cancer under the Orano Med brand. Written by Ned Pagliarulo October 17, 2024October 17, 2024 Saving Bookmark this article Bookmarked
Biotechnology Sanofi, expanding in radiopharma, strikes a joint venture deal The French drugmaker will invest 300 million euros into a new entity that will develop lead isotope-based therapies for cancer under the Orano Med brand. Written by Ned Pagliarulo October 17, 2024October 17, 2024 Saving Bookmark this article Bookmarked